778
A.S. Vieira et al. / Tetrahedron 66 (2010) 773–779
CDCl3)
(75 MHz, CDCl3)
d
1.76 (s, 6H), 1.96 (s, 3H), 7.74 (s, 2H), 7.83 (s, 1H). 13C NMR
alcohol (81 mg; 0.75 mmol; 1.5 equiv) under a nitrogen atmo-
d
18.7, 25.2, 105.8, 106.2, 121.5, 125.0, 128.5, 131.6
sphere was stirred at 100 ꢁC for 2 h. The reaction was monitored
by TLC until consumption of 4a was complete. The crude product
6a was purified by column chromatography in hexanes–ethyl
acetate (98:2), affording 6a as a colorless oil in 93% yield
(124 mg).
(q, J¼37.5 Hz), 134.7, 160.2, 166.5. 19F NMR (282 MHz, CDCl3)
d 13.8
(s, CF3). GC–MS: m/z (relative intensity): 354 (3) [Mþ], 296 (37), 254
(46), 43 (100). HRMS (ESI, positive) m/z calcd for C15H12O3F6:
355.0769 (MþH)þ; found: 355.0775 (MþH)þ. IR (CHCl3 solution,
cmꢀ1): 3026, 2936, 1719, 1632, 1405, 1280, 1141, 777.
4.4.1. Benzyl 3-oxo-2-phenylbutanoate (6a). Colorless oil. 1H NMR
4.3.10. 5-(Naphthalen-2-yl)-2,2,6-trimethyl-4H-1,3-dioxin-4-one
(300 MHz, CDCl3)
J¼15.0 Hz, 1H), 5.40 (d, J¼15.0 Hz, 1H), 7.14–7.39 (m, 10H), 12.9 (s,
1H). 13C NMR (75 MHz, CDCl3)
27.2, 62.4, 71.2, 127.4, 128.0, 128.2,
128.4, 128.5, 129.1, 130.3, 132.2, 164.8, 206.2. GC–MS: m/z (relative
intensity): 268 (4) [Mþ], 208 (16), 160 (30), 118 (82), 91 (100), 43
(78). HRMS (ESI, positive) m/z calcd for C13H14O3: 219.1021
(MþH)þ; found: 219.1008 (MþH)þ. IR (CHCl3 solution, cmꢀ1): 3015,
2937, 1717, 1632, 1397, 1275.
d 1.85 (s, 3H), 2.15 (s, 3H), 4.72 (s, 1H), 5.11 (d,
(4j). White solid, mp 119–120 ꢁC. 1H NMR (300 MHz, CDCl3)
d
1.79
(s, 6H), 2.04 (s, 3H), 7.38 (dd, J¼8.4, 1.8 Hz, 1H), 7.44–7.49 (m, 2H),
7.72 (s, 1H), 7.79–7.85 (m, 3H). 13C NMR (75 MHz, CDCl3)
18.6, 25.1,
d
d
105.3, 108.1, 126.0, 126.1, 127.5, 127.8, 127.9, 128.2, 129.6, 129.8,
132.6, 133.0, 161.2, 165.3. GC–MS: m/z (relative intensity): 268 (2)
[Mþ], 184 (27), 141 (100), 115 (23), 43 (27). HRMS (ESI, positive) m/z
calcd for C17H16O3, 269.1178 (MþH)þ; found: 269.1186 (MþH)þ. IR
(CHCl3 solution, cmꢀ1): 3015, 2938, 1716, 1628, 1398, 1277, 1203,
1026, 772.
4.4.2. (RþS)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl
3-oxo-2-
phenylbutanoate (6b). Colorless oil. 1H NMR (300 MHz, CDCl3)
4.3.11. 5,50-(1,4-Phenylene)-bis-(2,2,6-trimethyl-4H-1,3-dioxin-4-
(ketoþenol)
d
0.73 (d, J¼7.2 Hz, 3H), 0.86 (d, J¼7.1 Hz, 3H), 0.95 (d,
one) (4k). White solid, mp 171–172 ꢁC. 1H NMR (300 MHz, CDCl3)
J¼7.1 Hz, 3H), 1.52–1.76 (m, 6H), 1.84 (s, 3H), 1.88–2.09 (m, 3H),
2.18 (s, 3H), 4.66 (s, 1H), 4.73–4.89 (m, 1H), 7.11 (d, J¼8.5 Hz, 2H),
7.26–7.37 (m, 3H), 13.1 (s, 1H). 13C NMR (75 MHz, CDCl3) (keto-
d
1.77 (s, 12H), 2.14 (6H), 7.34 (s, 4H). 13C NMR (75 MHz, CDCl3)
d
18.9, 25.8, 101.2, 107.8, 130.1, 158.7, 167.2. GC–MS: m/z (relative
intensity): 358 (1) [Mþ], 217 (32), 141 (21), 43 (100). HRMS (ESI,
positive) m/z calcd for C20H22O6: 359.1495 (MþH)þ; found:
359.1499 (MþH)þ. IR (CHCl3 solution, cmꢀ1): 3016, 2948, 1718,
1630, 1391, 1275, 1208, 1010, 772.
þenol)
d 15.9, 16.1, 20.6, 20.7, 21.9, 23.2, 23.3, 25.9, 26.0, 31.3, 31.4,
34.1, 40.5, 46.6, 46.9, 65.9, 75.8, 104.7, 126.7, 127.8, 128.1, 128.7,
129.3, 131.1, 132.8, 132.9, 135.3, 168.1, 172.2, 173.5, 201.5. GC–MS:
m/z (relative intensity): 316 (4) [Mþ], 178 (20), 160 (23), 136 (28),
118 (100), 83 (56), 69 (34), 55 (24), 43 (64). HRMS (ESI, positive)
m/z calcd for C20H28O3: 317.2117 (MþH)þ; found: 317.2108
(MþH)þ. IR (CHCl3 solution, cmꢀ1): 3009, 2941, 1757, 1729, 1638,
1510, 1285.
4.3.12. 2,2,6-Trimethyl-5-(thiophen-3-yl)-4H-1,3-dioxin-4-one
(4l). Yellow oil. 1H NMR (300 MHz, CDCl3)
d 1.71 (s, 6H), 2.01 (s,
3H), 7.05 (dd, J¼4.9, 1.2 Hz, 1H), 7.21 (dd, J¼3.0, 1.2 Hz, 1H), 7.28
(dd, J¼4.9, 3.0 Hz, 1H). 13C NMR (75 MHz, CDCl3)
d 18.8, 25.1,
103.5, 105.2, 124.8, 124.9, 129.3, 132.0, 160.8, 165.2. GC–MS: m/z
(relative intensity): 224 (10) [Mþ], 166 (100), 124 (91), 96 (42), 70
(33), 57 (25), 43 (28). HRMS (ESI, positive) m/z calcd for
C11H12SO3: 225.0506 (MþH)þ; found: 225.0519 (MþH)þ. IR
(CHCl3 solution, cmꢀ1): 3010, 2941, 1719, 1630, 1270, 1209, 1012,
778.
4.4.3. (RþS)-(R)-(3,7-Dimethyl-oct-6-enyl)-3-oxo-2-phenyl-
butanoate (6c). Colorless oil. 1H NMR (300 MHz, CDCl3) (keto-
þenol)
d
0.88 (d, J¼7.2 Hz, 3H), 1.23–1.50 (m, 4H), 1.61 (s, 3H),
1.70 (s, 3H), 1.82–1.96 (m, 2H), 2.14 (s, 3H), 2.23 (s, 3H), 4.12 (t,
J¼7.3 Hz, 2H), 4.62 (s, 1H), 5.09 (t, J¼6.0 Hz, 1H), 7.23–7.51 (m,
5H). 13C NMR (75 MHz, CDCl3) (ketoþenol)
d 18.9, 19.1, 20.8, 23.1,
24.4, 27.8, 35.5, 37.6, 62.4, 70.3, 124.5, 127.5, 128.4, 129.1, 131.8,
138.5, 169.8, 174.3, 105.7, 203.7. GC–MS: m/z (relative intensity):
316 (2) [Mþ], 274 (33), 179 (48), 160 (100), 138 (44), 118 (77), 95
(52), 81 (62), 69 (70), 55 (47), 43 (66), 41 (89). HRMS (ESI, pos-
itive) m/z calcd for C20H28O3: 317.2117 (MþH)þ; found: 317.2123
(MþH)þ. IR (CHCl3 solution, cmꢀ1): 3010, 2945, 1753, 1728, 1630,
1513, 1275.
4.3.13. 2,2-Dimethyl-5,6-diphenyl-1,3-dioxin-4-one (4m). White solid.
Mp 151–152 ꢁC. 1H NMR (300 MHz, CDCl3)
d 1.78 (s, 6H), 7.29 (d,
J¼8.2 Hz, 2H), 7.38–7.56 (m, 6H), 7.88 (d, J¼8.0 Hz, 2H). 13C NMR
(75 MHz, CDCl3)
d 26.1, 102.5, 104.8, 127.1, 127.8, 128.2, 128.5, 128.7,
128.8, 130.1, 132.3, 161.7, 168.2. GC–MS: m/z (relative intensity): 280
(3) [Mþ], 225 (56), 175 (35), 120 (27), 105 (100), 91 (45), 77 (20).
HRMS (ESI, positive) m/z calcd for C18H16O3: 281.1178 (MþH)þ;
found: 281.1190 (MþH)þ. IR (CHCl3 solution, cmꢀ1): 3011, 2940,
1718, 1632, 1273, 1207, 1010, 779.
4.4.4. (SþR)-(R)-(Octan-2-yl)-3-oxo-2-phenylbutanoate
(6d). Colorless oil. 1H NMR (300 MHz, CDCl3) (ketoþenol)
d 0.88
(t, J¼7.3 Hz, 3H), 1.25–1.31 (m, 8H), 1.37 (d, J¼7.2 Hz, 3H), 1.53 (q,
J¼7.3H, 2H), 2.13 (s, 3H), 2.24 (s, 3H), 4.07 (sext, J¼7.3 Hz, 1H),
4.40 (s, 1H), 7.20–7.35 (m, 5H). 13C NMR (75 MHz, CDCl3) (keto-
4.3.14. 5-(4-Methoxyphenyl)-2,2-dimethyl-6-phenyl-1,3-dioxin-4-
one (4n). White solid. Mp 175–173 ꢁC. 1H NMR (300 MHz, CDCl3)
d
1.81 (s, 6H), 3.85 (s, 3H), 6.93 (d, J¼8.1 Hz, 2H), 7.31 (d, J¼8.1 Hz,
þenol)
d 14.1, 20.2, 22.7, 23.1, 27.8, 29.0, 29.3, 31.8, 36.7, 62.7,
2H), 7.38–7.50 (m, 3H), 7.95 (d, J¼8.2 Hz, 2H). 13C NMR (75 MHz,
72.3, 103.4, 128.1, 128.3, 129.7, 134.5, 168.0, 169.8, 174.3, 203.6.
GC–MS: m/z (relative intensity): 290 (2) [Mþ], 247 (23), 177 (32),
133 (25), 113 (35), 77 (12), 57 (13), 43 (100). HRMS (ESI, positive)
m/z calcd for C18H26O3: 291.1960 (MþH)þ; found: 291.1978
(MþH)þ. IR (CHCl3 solution, cmꢀ1): 3012, 2947, 1754, 1729, 1631,
1510, 1279.
CDCl3)
d 25.8, 56.4, 101.6, 103.5, 113.8, 125.9, 126.6, 127.8, 128.3,
128.8, 139.4, 146.3, 160.9, 168.5. GC–MS: m/z (relative intensity):
310 (16) [Mþ], 282 (45), 252 (76), 233 (25), 207 (10), 152 (21), 103
(42), 77 (13). HRMS (ESI, positive) m/z calcd for C19H18O4: 311.1284
(MþH)þ; found: 311.1290 (MþH)þ. IR (CHCl3 solution, cmꢀ1): 3010,
2942, 1718, 1635, 1279, 1207, 779.
4.4.5. Allyl 3-oxo-2-phenylbutanoate (6e). Colorless oil. 1H NMR
4.4. General procedure for reaction of 5-phenyl-2,2,6-
trimethyl-1,3-dioxin-4-one with benzylic alcohol
(300 MHz, CDCl3) (ketoþenol)
d 2.13 (s, 3H), 2.25 (s, 3H), 4.49 (s,
1H), 4.75 (d, J¼6.1 Hz, 2H), 5.28 (dd, J¼16.3, 3.2 Hz, 1H), 5.42 (dd,
J¼10.1, 3.2 Hz, 1H), 6.06 (dd, J¼16.3, 10.1 Hz, 1H), 12.7 (s, 1H). 13C
The preparation of benzyl 3-oxo-2-phenylbutanoate (6a) is
NMR (75 MHz, CDCl3) (ketoþenol)
d 23.5, 27.8, 62.6, 78.6, 101.2,
representative.
A
mixture of 5-phenyl-2,2,6-trimethyl-1,3-di-
118.1, 128.3, 128.7, 129.0, 132.5, 133.9, 168.3, 169.1, 172.8, 202.8. GC–
oxin-4-one 4a (109 mg; 0.50 mmol; 1.0 equiv) and benzylic
MS: m/z (relative intensity): 218 (2) [Mþ], 177 (23), 175 (32), 43